AMAM

Ambrx Biopharma (AMAM)

Ambrx Biopharma Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NYSE:AMAM

1 2 3 4 5 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2023/10/13	05:20	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NYSE:AMAM	Ambrx Biopharma Inc
2023/10/13	05:15	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NYSE:AMAM	Ambrx Biopharma Inc
2023/10/13	05:10	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NYSE:AMAM	Ambrx Biopharma Inc
2023/10/13	05:05	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NYSE:AMAM	Ambrx Biopharma Inc
2023/10/12	19:04	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:AMAM	Ambrx Biopharma Inc
2023/10/11	05:49	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:AMAM	Ambrx Biopharma Inc
2023/10/11	00:35	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NYSE:AMAM	Ambrx Biopharma Inc
2023/10/07	05:07	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:AMAM	Ambrx Biopharma Inc
2023/09/26	06:24	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NYSE:AMAM	Ambrx Biopharma Inc
2023/07/08	05:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:AMAM	Ambrx Biopharma Inc
2023/06/29	05:46	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:AMAM	Ambrx Biopharma Inc
2023/06/29	05:07	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:AMAM	Ambrx Biopharma Inc
2023/06/10	05:12	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:AMAM	Ambrx Biopharma Inc
2023/06/10	05:06	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:AMAM	Ambrx Biopharma Inc
2023/06/10	05:06	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:AMAM	Ambrx Biopharma Inc
2023/06/10	05:06	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:AMAM	Ambrx Biopharma Inc
2023/06/09	05:06	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:AMAM	Ambrx Biopharma Inc
2023/05/26	05:08	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NYSE:AMAM	Ambrx Biopharma Inc
2023/05/19	05:28	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NYSE:AMAM	Ambrx Biopharma Inc
2023/05/19	05:24	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:AMAM	Ambrx Biopharma Inc
2023/05/17	05:07	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NYSE:AMAM	Ambrx Biopharma Inc
2023/05/12	05:08	Edgar (US Regulatory)	Quarterly Report (10-q)	NYSE:AMAM	Ambrx Biopharma Inc
2023/05/06	05:10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:AMAM	Ambrx Biopharma Inc
2023/05/06	05:06	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NYSE:AMAM	Ambrx Biopharma Inc
2023/05/05	05:12	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:AMAM	Ambrx Biopharma Inc
2023/04/29	07:04	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:AMAM	Ambrx Biopharma Inc
2023/04/29	07:01	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:AMAM	Ambrx Biopharma Inc
2023/04/29	05:22	Edgar (US Regulatory)	Annual Report to Security Holders (ars)	NYSE:AMAM	Ambrx Biopharma Inc
2023/04/29	05:09	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NYSE:AMAM	Ambrx Biopharma Inc
2023/04/28	05:11	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NYSE:AMAM	Ambrx Biopharma Inc